External beam radiotherapy (EBRT), concomitant cisplatin and magnetic-resonance-imaging guided adaptive brachytherapy (IGABT) performed according to the EMBRACE-II study protocol is considered state-of-the-art for treatment of locally advanced cervical cancer (LACC).
The aim of the present study was to evaluate the possibilities for realizing the planning aims and to assess the clinical outcome from using the EMBRACE-II treatment principles in real-world patients.
